R Pallares

Author PubWeight™ 49.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992 3.37
2 Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987 2.78
3 Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998 2.40
4 Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med 1988 2.24
5 Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010 1.98
6 Fluoroquinolone resistance in Streptococcus pneumoniae. N Engl J Med 1999 1.96
7 Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994 1.85
8 Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995 1.78
9 Impact of a resident strike on emergency department quality indicators at an urban teaching hospital. Acad Emerg Med 2001 1.68
10 Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis 1995 1.67
11 Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996 1.61
12 Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 1994 1.61
13 Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med 1992 1.58
14 In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995 1.35
15 Specific antibodies detected during relapse of human brucellosis. J Infect Dis 1988 1.33
16 Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother 2007 1.28
17 Pneumococcal peritonitis in adult patients: report of 64 cases with special reference to emergence of antibiotic resistance. Arch Intern Med 2001 1.19
18 High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1996 1.11
19 Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob Agents Chemother 1989 1.09
20 Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997 1.08
21 Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. J Urol 1993 1.00
22 A single daily dose of ceftriaxone for bacterial meningitis in adults: experience with 84 patients and review of the literature. Clin Infect Dis 1995 0.96
23 Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone. Microb Drug Resist 2001 0.96
24 A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. J Gastrointest Surg 2008 0.92
25 High prevalence of genetically-determined mannose binding lectin deficiency in young children with invasive pneumococcal disease. Clin Microbiol Infect 2014 0.86
26 Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatology 1986 0.84
27 Intravenous ciprofloxacin therapy in severe infections. Am J Med 1989 0.83
28 Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998 0.83
29 Factors influencing length of hospital stay in community-acquired pneumonia: a study in 27 community hospitals. Epidemiol Infect 2004 0.83
30 Efficacy and safety of an early discharge protocol in low-risk patients with upper gastrointestinal bleeding. Am J Med 1998 0.82
31 Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989-2008). Clin Microbiol Infect 2011 0.81
32 Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med 1986 0.80
33 Cephalosporins as risk factor for enterococcal nosocomial urinary tract infections. Lancet 1986 0.80
34 Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990 0.79
35 Evolution and genetic diversity of the Spain23F-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990-2012). J Antimicrob Chemother 2013 0.79
36 Antibiotic resistance in respiratory pathogens. Curr Opin Pulm Med 1998 0.77
37 Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 2003 0.76
38 Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000 0.75
39 Catheter-related sepsis: pathogenesis and treatment. Am J Med 1987 0.75
40 [Hypoaldosteronism]. Rev Clin Esp 1983 0.75
41 Correction: catheter-related sepsis. Am J Med 1987 0.75
42 Antibiotic resistance in respiratory pathogens. Curr Opin Infect Dis 1998 0.75
43 Role of appropriate antimicrobial therapy in outcome of enterococcal bacteremia. Am J Med 1987 0.75
44 Geographical differences for pneumococcal disease. Lancet 2001 0.75
45 Amyloidosis (AA type) associated with nodular nonsuppurative panniculitis. Ann Intern Med 1983 0.75